Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 1170 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1Evidence-based practice use of quick-release bromocriptine across the natural history of type 2 diabetes mellitus
Stanley S. Schwartz,Farhad Zangeneh
Postgraduate Medicine.2016;128(8)828
[DOI]
2Bromocriptine mesylate QR in treatment of Type 2 diabetes
George Grunberger
Diabetes Management.2014;4(2)203
[DOI]
3Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases
Alexander O Shpakov,Kira V Derkach,Lev M Berstein
Future Science OA.2015;1(3)203
[DOI]
4A review of dopamine agonist therapy in type 2 diabetes and effects on cardio-metabolic parameters
E.M. Lamos,D.L. Levitt,K.M. Munir
Primary Care Diabetes.2016;10(1)60
[DOI]
5A review of dopamine agonist therapy in type 2 diabetes and effects on cardio-metabolic parameters
Shamsa Ali,Vivian Fonseca
Primary Care Diabetes.2015;10(1)758
[DOI]
6The effect of dopamine agonists on metabolic variables in adults with type 2 diabetes: A systematic review with meta analysis and trial sequential analysis of randomized clinical trials
Ida Brandt Andersen,Mikkel Andreassen,Jesper Krogh
Diabetes, Obesity and Metabolism.2021;23(1)58
[DOI]
7Bromocriptine mesylate improves glucose tolerance and disposal in a high-fat-fed canine model
Mary Courtney Moore,Marta S. Smith,Larry L. Swift,Anthony H. Cincotta,Michael Ezrokhi,Nicholas Cominos,Yahong Zhang,Ben Farmer,Alan D. Cherrington
American Journal of Physiology-Endocrinology and Metabolism.2020;319(1)E133
[DOI]
8A review of the efficacy and safety of oral antidiabetic drugs
Stephanie Aleskow Stein,Elizabeth Mary Lamos,Stephen N Davis
Expert Opinion on Drug Safety.2013;12(2)153
[DOI]
9Late phase completed clinical trials investigating bromocriptine mesylate quick release as treatment of type 2 diabetes mellitus
Maka Siamashvili,Stephen Davis
Expert Opinion on Pharmacotherapy.2021;22(2)241
[DOI]
10Late phase completed clinical trials investigating bromocriptine mesylate quick release as treatment of type 2 diabetes mellitus
Md. Akil Hossain,Rokeya Pervin
Expert Opinion on Pharmacotherapy.2018;22(2)455
[DOI]
  Feedback 
  Subscribe 

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal